Created page with "__NOTOC__ {{Percutaneous Coronary Intervention}} {{CMG}} ==ACCF/AHA 2011 Guidelines for Percutaneous Coronary Intervention: Revascularization Before Non-cardiac Surgery
__NOTOC__
{{Percutaneous Coronary Intervention}}
{{CMG}}
==ACCF/AHA 2011 Guidelines for Percutaneous Coronary Intervention: Revascularization Before Non-cardiac Surgery
{{cite journal |author=Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH |title=2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions |journal=[[Journal of the American College of Cardiology]] |volume=58 |issue=24 |pages=2550–83 |year=2011 |month=December|pmid=22070837|doi=10.1016/j.jacc.2011.08.006|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(11)02875-0|accessdate=2011-12-08|url=http://content.onlinejacc.org/cgi/reprint/58/24/2550.pdf|PDF}}
(DO NOT EDIT)==
{|class="wikitable"
|-
|colspan="1" style="text-align:center; background:LightCoral"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] (No Benefit)
|-
|bgcolor="LightCoral"|
"
'''1.''' Routine prophylactic [[Chronic stable angina revascularization|coronary revascularization]] should not be performed in patients with [[Chronic stable angina|stable CAD]] before noncardiac surgery.
{{cite journal |author=Cinà CS, Devereaux PJ |title=Coronary-artery revascularization before elective major vascular surgery. McFalls EO, ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, Pierpont G, Santilli S, Rapp J, Hattler B, Shunk K, Jaenicke C, Thottapurathu L, Ellis N, Reda DJ, Henderson WG. N Engl J Med. 2004; 351: 2795-804 |journal=[[Vascular Medicine (London, England)]] |volume=11 |issue=1 |pages=61–3 |year=2006 |month=February |pmid=16669417 |doi=|url=http://vmj.sagepub.com/cgi/pmidlookup?view=long&pmid=16669417|accessdate=2011-12-08}}
{{cite journal |author=Schouten O, van Kuijk JP, Flu WJ, Winkel TA, Welten GM, Boersma E, Verhagen HJ, Bax JJ, Poldermans D |title=Long-term outcome of prophylactic coronary revascularization in cardiac high-risk patients undergoing major vascular surgery (from the randomized DECREASE-V Pilot Study) |journal=[[The American Journal of Cardiology]] |volume=103 |issue=7 |pages=897–901 |year=2009 |month=April |pmid=19327412|doi=10.1016/j.amjcard.2008.12.018|url=http://linkinghub.elsevier.com/retrieve/pii/S0002-9149(08)02173-5|accessdate=2011-12-08}}
''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''
"
|-
|bgcolor="LightCoral"|
"
'''2.''' Elective non-cardiac surgery should not be performed in the 4 to 6 weeks after [[balloon angioplasty]] or [[Bare metal stent|BMS implantation]] or the 12 months after [[Drug eluting stent|DES implantation]] in patients in whom the [[Platelet aggregation inhibitor|P2Y12 inhibitor]] will need to be discontinued peri-operatively.
{{cite journal |author=Grines CL, Bonow RO, Casey DE, Gardner TJ, Lockhart PB, Moliterno DJ, O'Gara P, Whitlow P |title=Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians |journal=[[Journal of the American College of Cardiology]] |volume=49 |issue=6 |pages=734–9 |year=2007 |month=February|pmid=17291948 |doi=10.1016/j.jacc.2007.01.003|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(07)00054-X|accessdate=2011-12-08}}
{{cite journal |author=Sharma AK, Ajani AE, Hamwi SM, Maniar P, Lakhani SV, Waksman R, Lindsay J |title=Major noncardiac surgery following coronary stenting: when is it safe to operate? |journal=[[Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions]] |volume=63|issue=2 |pages=141–5 |year=2004 |month=October |pmid=15390248 |doi=10.1002/ccd.20124|url=http://dx.doi.org/10.1002/ccd.20124 |accessdate=2011-12-08}}
{{cite journal |author=Kałuza GL, Joseph J, Lee JR, Raizner ME, Raizner AE|title=Catastrophic outcomes of noncardiac surgery soon after coronary stenting |journal=[[Journal of the American College of Cardiology]] |volume=35 |issue=5 |pages=1288–94 |year=2000 |month=April|pmid=10758971 |doi= |url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(00)00521-0|accessdate=2011-12-08}}
{{cite journal |author=Win HK, Caldera AE, Maresh K, Lopez J, Rihal CS, Parikh MA, Granada JF, Marulkar S, Nassif D, Cohen DJ, Kleiman NS|title=Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents|journal=[[JAMA : the Journal of the American Medical Association]] |volume=297 |issue=18|pages=2001–9 |year=2007 |month=May |pmid=17488965 |doi=10.1001/jama.297.18.2001|url=http://jama.ama-assn.org/cgi/pmidlookup?view=long&pmid=17488965 |accessdate=2011-12-08}}
''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''
"
|}
{|class="wikitable"
|-
| colspan="1" style="text-align:center; background:LemonChiffon"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]]
|-
|bgcolor="LemonChiffon"|
"
'''1.''' 1. For patients who require [[ST elevation myocardial infarction primary percutaneous coronary intervention|PCI]] and are scheduled for elective non-cardiac surgery in the subsequent 12 months, a strategy of [[balloon angioplasty]], or [[Bare metal stent|BMS implantation]] followed by 4 to 6 weeks of [[Dual antiplatelet therapy|dual antiplatelet therapy (DAPT)]], is reasonable.
{{cite journal |author=Berger PB, Bell MR, Hasdai D, Grill DE, Melby S, Holmes DR|title=Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement |journal=[[Circulation]] |volume=99 |issue=2 |pages=248–53 |year=1999 |month=January|pmid=9892591 |doi= |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=9892591|accessdate=2011-12-08}}
{{cite journal |author=Cruden NL, Harding SA, Flapan AD, Graham C, Wild SH, Slack R, Pell JP, Newby DE |title=Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery |journal=[[Circulation. Cardiovascular Interventions]] |volume=3 |issue=3 |pages=236–42 |year=2010 |month=June |pmid=20442357|doi=10.1161/CIRCINTERVENTIONS.109.934703|url=http://circinterventions.ahajournals.org/cgi/pmidlookup?view=long&pmid=20442357|accessdate=2011-12-08}}
{{cite journal |author=Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF |title=2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery |journal=[[Journal of the American College of Cardiology]] |volume=54|issue=22 |pages=e13–e118 |year=2009 |month=November |pmid=19926002 |doi=10.1016/j.jacc.2009.07.010|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(09)02385-7|accessdate=2011-12-08}}
{{cite journal |author=Kałuza GL, Joseph J, Lee JR, Raizner ME, Raizner AE |title=Catastrophic outcomes of noncardiac surgery soon after coronary stenting |journal=[[Journal of the American College of Cardiology]] |volume=35 |issue=5|pages=1288–94 |year=2000 |month=April |pmid=10758971 |doi=|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(00)00521-0|accessdate=2011-12-08}}
{{cite journal |author=Reddy PR, Vaitkus PT|title=Risks of noncardiac surgery after coronary stenting |journal=[[The American Journal of Cardiology]] |volume=95 |issue=6 |pages=755–7 |year=2005 |month=March |pmid=15757604|doi=10.1016/j.amjcard.2004.11.029|url=http://linkinghub.elsevier.com/retrieve/pii/S0002-9149(04)01882-X|accessdate=2011-12-08}}
{{cite journal |author=Sharma AK, Ajani AE, Hamwi SM, Maniar P, Lakhani SV, Waksman R, Lindsay J |title=Major noncardiac surgery following coronary stenting: when is it safe to operate? |journal=[[Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions]] |volume=63|issue=2 |pages=141–5 |year=2004 |month=October |pmid=15390248 |doi=10.1002/ccd.20124|url=http://dx.doi.org/10.1002/ccd.20124 |accessdate=2011-12-08}}
{{cite journal |author=Wilson SH, Fasseas P, Orford JL, Lennon RJ, Horlocker T, Charnoff NE, Melby S, Berger PB |title=Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting |journal=[[Journal of the American College of Cardiology]] |volume=42 |issue=2 |pages=234–40 |year=2003 |month=July |pmid=12875757 |doi=|url=http://linkinghub.elsevier.com/retrieve/pii/S0735109703006223 |accessdate=2011-12-08}}
''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''
"
|-
|bgcolor="LemonChiffon"|
"
'''2.''' For patients with [[Drug eluting stent|drug eluting stent (DES)]] who must undergo urgent surgical procedures that mandate the discontinuation of [[Dual antiplatelet therapy|dual antiplatelet therapy (DAPT)]], it is reasonable to continue [[ST elevation myocardial infarction aspirin therapy|aspirin]] if possible and restart the [[Platelet aggregation inhibitor|P2Y12 inhibitor]] as soon as possible in the immediate postoperative period.
{{cite journal |author=Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF |title=2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery |journal=[[Journal of the American College of Cardiology]] |volume=54 |issue=22 |pages=e13–e118 |year=2009 |month=November|pmid=19926002 |doi=10.1016/j.jacc.2009.07.010|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(09)02385-7|accessdate=2011-12-08}}
{{cite journal |author=Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW |title=ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery |journal=[[Journal of the American College of Cardiology]] |volume=50 |issue=17 |pages=1707–32 |year=2007 |month=October |pmid=17950159|doi=10.1016/j.jacc.2007.09.001|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(07)02724-6|accessdate=2011-12-08}}
''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''
"
|}
==References==
{{reflist|2}}
{{WH}}
{{WS}}
[[Category:Disease]]
[[Category:Cardiology]]
[[Category:Up-To-Date]]
[[Category:Up-To-Date cardiology]]